XORTX Therapeutics XRTX
NASDAQ XRTX
$1.70 0.00 (-0.28%)
As of: Sep 30, 2026 · 10:23 AM EDT

XORTX Therapeutics (XRTX) Short term Debt (2022 - 2023)

Updated

XORTX Therapeutics (XRTX) posted Short term Debt of $61,536 for the quarter ended Mar 31, 2023, down 6.7% from the prior quarter.

Analysis

XORTX Therapeutics (XRTX) Short term Debt (2022 - 2023) Analysis & Trends

As of Dec 31, 2022, XORTX Therapeutics' Short term Debt came in at $68,853.

  • According to Business Quant data, Short term Debt for the three prior quarters was $65,947 (quarter ended Dec 31, 2022), $67,333 (quarter ended Sep 30, 2022) and $67,556 (quarter ended Jun 30, 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 XORTX Therapeutics 1.62 Mn -1.68 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 61,536.00
Dec 31, 2022 65,947.44
Sep 30, 2022 67,333.36
Jun 30, 2022 67,556.04
API Access

XORTX Therapeutics Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=XRTX&period=max&api_key=YOUR_API_KEY